rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Euda Health Holdings Limited -

EUDA · Nasdaq

Health CareProviders & FacilitiesJust started moving

EUDA stood above a rising 150-day average in 1 of the last 52 weekly readings, including each of the last 1 week. It is 6.9% above that average now. Providers & Facilities: 43% of its 53 stocks in an uptrend (−4 points in four weeks); Health Care: 26% (−10 points in four weeks).

Statistics

Rotation
Just started moving
Weeks in an uptrend
1 in a row
Industry in uptrend
43% -4 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
1

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 1 of 52 weeks.

20 Apr – 19 Oct
27%43%59%Apr 26Jun 26Jul 26Sep 26Oct 26

Providers & Facilities: About half its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders1
New · exited1 · 0
Reported value$308

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
UBS Group AGnew · filed 13 Aug 202622$308+22
31 Mar 2023 – 30 Jun 2026
158Mar 23Dec 23Sep 24Jun 25Jun 26

News

No headline names it lately.

Everyone who traded it

Wei Wen Kelvin Chen Company insiderCHIEF EXECUTIVE OFFICER · last 12 Jun 20230 · 0
Meng Dong (James) Tan Company insider10% owner · last 17 Nov 20221 · 0

Same industry

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202543.9%
Operating profit marginFY 2025 · to 31 Dec 2025-36.3%
Free cash flow marginFY 2025 · to 31 Dec 2025-36.7%
Research spendFY 2025 · to 31 Dec 20250.0%
Revenue growthFY 2025 · to 31 Dec 202570.0%
Share count trendFY 2025 · to 31 Dec 2025-94.9%
Cash and equivalentsFY 2025 · to 31 Dec 2025$345K
Free cash flowFY 2025 · to 31 Dec 2025−$2.5M

Analyst forecasts

No analyst forecasts yet.